Search Results - "Spaepen, E"

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005 by Annemans, L, Spaepen, E, Gaskin, M, Bonnemaire, M, Malier, V, Gilbert, T, Nuki, G

“…To investigate and compare the prevalence, comorbidities and management of gout in practice in the UK and Germany. A retrospective analysis of patients with…”
Get more information

Baseline Patient, Ocular Features and Management of a Patient Population Diagnosed with Vitreomacular Traction: An Observational Study in Flanders by Lescrauwaet, B, Spaepen, E, Vriens, I, Stalmans, P

Get full text

HOSPITAL-ACQUIRED INFECTIONS IN BELGIAN ACUTE-CARE HOSPITALS: FINANCIAL BURDEN OF DISEASE AND POTENTIAL COST SAVINGS by Trybou, J, Spaepen, E, Vermeulen, B, Porrez, L, Annemans, L

“…Introduction: Hospital Acquired Infections (HAIs) are considered to be one of the most serious patient safety issues in healthcare today. It has been shown…”
Get full text

COSTS ASSOCIATED WITH READMISSIONS IN BELGIAN ACUTE-CARE HOSPITALS by Trybou, J, Spaepen, E, Vermeulen, B, Porrez, L, Annemans, L

“…Introduction: Internationally, hospital readmissions have a great appeal as an indicator of hospital quality. Since possibilities in prevention and control…”
Get full text

PCN33 Cost Analysis: Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in Spain by Duran, A, Spaepen, E, Lamotte, M, Brosa, M, Gutierrez, L, Restovic, G, Annemans, L

Get full text

PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH by Duran, A, Spaepen, E, Lamotte, M, Walter, E, Lucioni, C, Pinheiro, B, Brosa, M, Kutikova, L, Pujol, B, Annemans, L

Get full text

PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy by Duran, A, Spaepen, E, Lamotte, M, Lucioni, C, Kutikova, L, Pujol, B, Gozzo, M, Annemans, L

Get full text

CO123 An Indirect Comparison of Efgartigimod Versus Rituximab for Generalized Myasthenia Gravis by Celico, L, Spaepen, E, De Francesco, M, Iannazzo, S

Get full text

CO144 A Trial-Based Health Utility Analysis in Patients with Acanthamoeba Keratitis by Alves, A., Spaepen, E., De Francesco, M., Gissara, F., Tofani, L.

Get full text

EPH161 Epidemiology Landscape and Impact of Obesity: Multi-Country Results from the Impact-O Study by Artime, E., Spaepen, E., Adam, A., Lin, X., Shang, M., Seager, S., Mount, J.E., Tahbaz, A.

Get full text

PDB6 Indirect Treatment Comparison (ITC) of ULTRA-RAPID Lispro Insulin (URLI) Versus FAST-Acting Insulin Aspart (FASTER ASPART) in Patients with Type 1 Diabetes (T1DM) by Osumili, B., Paczkowski, R., Spaepen, E., Liao, B., Tobian, J.

Get full text

PCR136 Patient and Health Care Professional Experiences of Suboptimal Insulin Dosing by Newson, RS, Hadi, M, Barnes, N, Sargalo, N, Clark, A, Spaepen, E

Get full text

POSB372 Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Diabetes Patients in the UK and US by Heidenreich, S, Seo, J, Aldalooj, E, Poon, JL, Spaepen, E, Eby, E, Newson, R

Get full text

Health economic consequences related to the diagnosis of fibromyalgia syndrome by Annemans, L., Wessely, S., Spaepen, E., Caekelbergh, K., Caubère, J. P., Lay, K. Le, Taïeb, C.

“…Objective To evaluate the use and costs of medical resources before and after a diagnosis of fibromyalgia syndrome (FMS) in a large primary care population in…”
Get full text

CO15 A Matching-Adjusted Indirect Comparison of Efgartigimod Versus Ravulizumab for Generalized Myasthenia Gravis by Celico, L, Spaepen, E, De Francesco, M, Chiroli, S, Iannazzo, S, Ruck, T, Meuth, SG

Get full text

PDB62 Profile of Patients Treated with Insulin Lispro 200 U/ML in the Real World: Profile IL-200 Study by Rubio, M., Artime, E., Duque, N., Spaepen, E., Carreño, Á., Díaz Cerezo, S.

Get full text

POSB393 Profile of Patients with Type 1 or Type 2 Diabetes Treated with Insulin Lispro 100 Units/ML Junior Kwikpen in Routine Clinical Practice in Spain by Rubio, M, Duque, N, Artime, E, Caveda, E, Spaepen, E, Díaz Cerezo, S, Ampudia-Blasco, FJ

Get full text

The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective by Bellido, Virginia, Duque, Natalia, Newson, Rachel S, Artime, Esther, Spaepen, Erik, Rubio de Santos, Miriam, Redondo-Antón, Jennifer, Díaz-Cerezo, Silvia, Navarro, Jorge

“…This study aimed to determine physicians' perceptions of the extent of suboptimal insulin dosing and the barriers and solutions to optimal dosing in people…”
Get full text

PDB119 - PATIENT PREFERENCES AND HEALTH STATE UTILITIES ASSOCIATED WITH MEALTIME INSULIN CONCENTRATIONS AMONG PATIENTS WITH DIABETES IN ITALY by Matza, L.S., Osumili, B., Stewart, K.D., Perez, M., Jordan, J., Biricolti, G., Romoli, E., Losi, S., Del Santo, S., Spaepen, E., Parola, G., Syrad, H., Boye, K.

Get full text

PSS5 - Baseline Patient, Ocular Features and Management of a Patient Population Diagnosed with Vitreomacular Traction: An Observational Study in Flanders by Lescrauwaet, B., Spaepen, E., Vriens, I., Stalmans, P.

Get full text